Should I Buy MCS? MCS 2026 Analysis

Should You Buy Marcus Corp (MCS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

16.480

1 Day change

0.55%

52 Week Range

21.730

Analysis Updated At

2026/02/20

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Marcus Corp (MCS) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive financial performance, absence of significant trading signals, and neutral trading sentiment suggest holding off on investment for now.

Technical Analysis

The MACD histogram is positive at 0.115 and expanding, indicating bullish momentum. RSI is at 75.85, which is neutral. Moving averages are converging, showing no clear trend. Resistance is at 16.503 and 16.892, while support is at 15.242 and 14.853.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

The stock has a 60% chance to increase by 7.87% in the next week and 10.55% in the next month based on historical candlestick patterns.

Neutral/Negative Catalysts

No significant news or events in the past week. Financial performance in Q3 2025 shows a decline in revenue (-10.24% YoY), net income (-30.39% YoY), and EPS (-28.77% YoY). Gross margin also dropped by 3.28%.

Financial Performance

In Q3 2025, revenue dropped to $199.5M (-10.24% YoY), net income dropped to $16.23M (-30.39% YoY), and EPS dropped to $0.52 (-28.77% YoY). Gross margin declined to 36.59% (-3.28% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available on recent analyst ratings or price target changes.

2 Analyst Rating

Wall Street analysts forecast MCS stock price to rise

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 16.390

Low

Averages

23.5

High

Current: 16.390

Low

Averages

23.5

High

Wedbush

Outperform

initiated

$24

AI Analysis

2025-07-18

Reason

Wedbush

Price Target

$24

AI Analysis

2025-07-18

initiated

Outperform

Reason

Wedbush initiated coverage of Marcus with an Outperform rating and $24 price target. The firm sees the company benefiting from a more consistent theatrical release slate over the next several quarters. Marcus is positioned to to raise its dividend back toward pre-pandemic rates and repurchase shares, the analyst tells investors in a research note. Wedbush adds that Marcus has room to monetize surplus real estate as it owns most of its properties. It has a positive bias on the shares.

B. Riley

Buy

downgrade

$26 -> $24

2025-05-16

Reason

B. Riley

Price Target

$26 -> $24

2025-05-16

downgrade

Buy

Reason

B. Riley lowered the firm's price target on Marcus to $24 from $26 and keeps a Buy rating on the shares following a transfer of coverage. The firm is "generally constructive" on the exhibitor space, saying the sector is underpinned by a strong Hollywood film slate for 2025 and 2026 that should fuel further box office recovery and benefit relevant industry participants. Riley also finds limited tariff risk and a history of movie-going resiliency during periods of economic weakness "to be additional market themes that are supportive of this favorable backdrop." The firm's top pick across the group is Imax (IMAX), followed by Marcus (MCS).

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MCS

Unlock Now

MCS Should I Buy

MCS Should I Buy

Should You Buy Marcus Corp (MCS) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch